[MDGL] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
26-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -29.45%
YoY- -141.74%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -85,905 -64,549 -59,123 -27,740 -11,475 -8,445 -7,749 49.29%
Tax 1,682 -106 -116 -28 -25 -276 142 50.95%
NP -87,587 -64,549 -59,123 -27,740 -11,475 -8,445 -7,749 49.77%
Tax Rate - - - - - - - -
Total Cost 87,587 64,549 59,123 27,740 11,475 8,445 7,749 49.77%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -5.08 -3.78 -3.82 -1.80 -0.75 -0.67 -0.67 40.14%
EPS Diluted -5.08 -3.78 -3.82 -1.80 -0.75 -0.67 -0.67 40.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.